v3.26.1
Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Cash flows from operating activities    
Net income $ 19,619 $ 40,253
Adjustments to reconcile net income to net cash provided by operating activities:    
Depreciation, depletion and amortization 7,614 3,989
Distributions from unconsolidated investment 0 2,940
Equity in (earnings) loss from unconsolidated investment 7,828 (4,610)
Loss (gain) on asset sales and disposals 1 (247)
Asset impairments 0 20
Bad debt expense (776) 451
Unit-based compensation expense 1,164 2,717
Amortization of debt issuance costs and other 447 (168)
Change in operating assets and liabilities:    
Accounts receivable 615 (149)
Accounts payable 1,290 546
Accrued liabilities (7,156) (7,990)
Accrued interest 210 254
Deferred revenue 1,434 (3,227)
Other items, net 724 (355)
Net cash provided by operating activities 33,014 34,424
Cash flows from investing activities    
Proceeds from asset sales and disposals 0 247
Capital to unconsolidated investment (39,200) 0
Return of long-term contract receivable 758 700
Net cash provided by (used in) investing activities (38,442) 947
Cash flows from financing activities    
Debt borrowings 61,200 33,700
Debt repayments (34,000) (37,000)
Distributions to unitholders (11,763) (26,276)
Other items, net (8,646) (5,363)
Net cash provided by (used in) financing activities 6,791 (34,939)
Net increase in cash and cash equivalents 1,363 432
Cash and cash equivalents at beginning of period 30,141 30,444
Cash and cash equivalents at end of period 31,504 30,876
Supplemental cash flow information:    
Cash paid for interest $ 684 $ 2,371